Corbus Pharmaceuticals Holdings, Inc. (CRBP) Net margin 2016–2021
Corbus Pharmaceuticals Holdings, Inc. (CRBP) net profit margin by fiscal year — reported net income divided by reported revenue.
-5176.4%FY2021 · since FY2016: -1046.3% → -5176.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -5176.4% | -2350.3 pp |
| FY2020 | -2826.1% | -2628.4 pp |
| FY2019 | -197.7% | +956.8 pp |
| FY2018 | -1154.5% | +174.2 pp |
| FY2017 | -1328.6% | -282.4 pp |
| FY2016 | -1046.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CRBP financial trends
CRBP RevenueCRBP Net incomeCRBP Gross profitCRBP Gross marginCRBP Operating incomeCRBP Operating marginCRBP Operating cash flowCRBP Free cash flowCRBP Capital expendituresCRBP Return on equityCRBP Stock buybacksCRBP Dividends paidCRBP Total assetsCRBP Total liabilitiesCRBP Shareholders’ equityCRBP overview →